The etiology and pathogenesis of the pregnancy syndrome preeclampsia remain poorly understood. There is substantial evidence to suggest that the diverse manifestations of preeclampsia, including altered vascular reactivity, vasospasm, and discrete pathology in many organ systems, are derived from pathologic changes within the maternal vascular endothelium. With the theme of endothelial cell dysfunction emphasized, this review focuses on the role of oxidative stress (an imbalance favoring oxidant over antioxidant forces) in the pathogenesis of preeclampsia. Data are summarized regarding 1) the role of the placenta in preeclampsia; 2) evidence and mechanisms of oxidative stress in the preeclampsia placenta; 3) markers of oxidative stress in the maternal circulation; and 4) the potential role of maternal dyslipidemia in generation of oxidative stress. A recurrent theme is that free radical reactions, promoted by “cross-talk” between the diseased placenta and maternal dyslipidemia, promote a vicious cycle of events that make cause and effect difficult to distinguish but likely contribute to the progression of preeclampsia.
MeisP, GoldenbergR, MercerB.The preterm prediction study: Risk factors for indicated preterm births. Maternal-Fetal Medicine Units Network of the National Institute of Child Health and Human Development. Am J Obstet Gynecol179: 562–567, 1998.
4.
FriedmanE, NeffR.Pregnancy outcome as related to hypertension, edema, and proteinuria. In: LindheimerM, KatzA, ZuspanF, Eds. Hypertension in Pregnancy. New York: John Wiley & Sons, p13, 1976.
5.
RobertsJ.Pregnancy-related hypertension. In: CreasyR, ResnikR, Eds. Maternal Fetal Medicine. Philadelphia: W. B. Saunders, pp 804–843, 1994.
6.
FriedmanSA, TaylorRN, RobertsJM. Pathophysiology of preeclampsia. Clin Perinatol18: 661–682, 1991.
RobertsJM. Endothelial dysfunction in preeclampsia. Sem Reprod Endocrinol16: 5–15, 1998.
11.
RedmanCW. Current topic: Preeclampsia and the placenta. Placenta12: 301–308, 1991.
12.
CrossJC. Trophoblast function in normal and preeclamptic pregnancy. Fetal Matern Med Rev8: 57–66, 1996.
13.
NessRB, RobertsJM. Heterogeneous causes constituting the single syndrome of preeclampsia: A hypothesis and its implications. Am J Obstet Gynecol175: 1365–1370, 1996.
14.
SattarN, GawA, PackardCJ, GreerIA. Potential pathogenic roles of abberrant lipoprotein and fatty acid metabolism in preeclampsia. Br J Obstet Gynaecol103: 614–620, 1996.
15.
HubelCA, RobertsJM, TaylorRN, MusciTJ, RogersGM, McLaughlinMK. Lipid peroxidation in pregnancy: New perspectives on preeclampsia. Am J Obstet Gynecol161: 1025–1034, 1989.
16.
HalliwellB, GutteridgeJM, CrossCE. Free radicals, antioxidants, and human disease: Where are we now?J Lab Clin Med119: 598–620, 1992.
17.
HalliwellB, ChiricoS.Lipid peroxidation: Its mechanism, measurement, and significance. Am J Clin Nutr57: 715S–725S, 1993.
FisherKA, LlugerA, SpargoBH, LindheimerMD. Hypertension in pregnancy: Clinical-pathological correlations and remote prognosis. Medicine60: 267–276, 1981.
28.
McCartneyCP, SpargoBH, LarinczAB, LefebureY, NewtonRE. Renal structure and function in pregnant patients with acute hypertension. Am J Obstet Gynecol90: 579–590, 1964.
29.
SpargoB, McCartneyC, WinemullerR.Glomerular capillary endo-theliosis in toxemia of pregnancy. Arch Pathol68: 593–599, 1959.
30.
PollakV, NettlesJ.The kidney in toxemia of pregnancy: A clinical and pathologic study based on renal biopsies. Medicine39: 469–477, 1960.
31.
KnockGA, PostonL.Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol175: 1668–1674, 1996.
32.
PascoalIF, LindheimerMD, Nalbantian-BrandtC, UmansJG. Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. J Clin Invest101: 464–470, 1998.
33.
NisellH, HjemdahlP, LineB.Cardiovascular responses to circulating catecholamines in normal pregnancy and pregnancy-induced hypertension. Clin Physiol5: 479–493, 1985.
34.
GantNF, DaleyGL, ChandS, WhalleyPJ, MacDonaldPC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest52: 2682–2689, 1973.
35.
BelfortMA, SaadeGR. Retinal vasospasm associated with visual disturbance in preeclampsia: Color flow doppler findings. Am J Obstet Gynecol169: 523–525, 1993.
36.
ValluriS, AdelbergDA, CurtisRS, OlkRJ. Diagnostic indocyanine green angiography in preeclampsia. Am J Ophthalmol122: 672–677, 1996.
37.
KraussT, JuhnW, LakomaC, AugustinHG. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol177: 443–449, 1997.
38.
TaylorRN, CrombleholmeWR, FriedmanSA, JonesLA, CasalDC, RobertsJM. High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol165: 895–901, 1991.
39.
DavidgeST, SignorellaAP, HubelCA, LykinsDL, RobertsJM. Distinct factors in plasma of preeclamptic women increase endothelial nitric oxide or prostacyclin. Hypertension28: 758–764, 1996.
40.
HubelCA, LyallF, WeissfeldL, GandleyRE, RobertsJM. Small low-density lipoproteins and vascular cell adhesion molecule (VCAM-1) are increased in association with hyperlipidemia in preeclampsia. Metabolism47: 1281–1288, 1998.
41.
HallerH, HempelA, HomuthV, MandelkowA, BusjahnA, MaaschC, DrabM, LindschauC, JupnerA, VetterK, DudenhausenJ, LuftFC. Endothelial-cell permeability and protein kinase C in preeclampsia. Lancet351: 945–949, 1998.
42.
ChwaliszK, BuhimschiI, GarfieldRE. Role of nitric oxide in obstetrics. Prenat Neonat Med1: 292–328, 1996.
43.
SeligmanSP, BuyonJP, ClancyRM, YoungBK, AbramsonSB. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol171: 944–948, 1994.
44.
DavidgeS, StrankoC, RobertsJ.Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol174: 1008–1013, 1996.
45.
NobunagaT, TokugawaY, HashimotoK, KimuraT, MatsuzakiN, NittaY, FujitaT, KidoguchiK, AzumaC, SajiF.Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension. Gynecol Obstet Invest41: 189–193, 1996.
46.
SmarasonA, AllmanK, YoungD, RedmanC.Women with preeclampsia have elevated levels of serum nitrate, a stable end product of nitric oxide. Br J Obstet Gynaecol104: 538–543, 1997.
47.
RantaV, ViinikkaL, HalmesmakiE, YlikorkalaO.Nitric oxide production with preeclampsia. Obstet Gynecol93: 442–445, 1999.
48.
SladekSM, MagnessRR, ConradKP. Nitric oxide and pregnancy. Am J Physiol41: R441–R463, 1997.
49.
PageEW. The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of preeclampsia. Am J Obstet Gynecol37: 291–293, 1939.
50.
ShembreyM, NobleA.An instructive case of abdominal pregnancy. Aust N Z J Obstet Gynaecol35: 220–221, 1995.
51.
PieringWF, GarancisJG, BeckerCG, BeresJA, LemannJ.Preeclampsia related to a functioning extrauterine placena: Report of a case and 25–year follow-up. Am J Kidney Dis21: 310–313, 1993.
52.
FisherSJ, RobertsJM. Defects in placentation and placental perfusion. In: LindheimerMD, RobertsJM, CunninghamFG, Eds. Chesley's Hypertensive Disorders in Pregnancy (2nd ed). Stamford, CT: Appleton & Lange, pp 377–394, 1999.
BrosensIA. Morphological changes in the uteroplacental bed in pregnancy hypertension. Clin Obstet Gynecol77: 573–593, 1977.
55.
SheppardBL, BonnarJ.An ultrastructural study of uteroplacental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynaecol88: 695–705, 1981.
WigglesworthJS. Morphologic variations in the insufficient placenta. J Obstet Gynecol71: 871–884, 1964.
59.
ChesleyLC. Hypertensive Disorders of Pregnancy. New York: Appleton-Century-Crofts, pp 460–461, 1978.
60.
TominagaT, PageEW. Accommodation of the human placenta to hypoxia. Am J Obstet Gynecol94: 679–685, 1966.
61.
ZamudioS, PalmerSK, RegensteinerJG, MooreLG. High altitude and hypertension during pregnancy. Am J Human Biol7: 183–193, 1995.
62.
DeWolfF, RobertsonWB, BrosensI.The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol123: 164–174, 1975.
63.
ZeekP, AssaliN.Vascular changes in the decidua associated with eclamptogenic toxemia. Am J Clin Pathol20: 1099–1109, 1950.
64.
FoxH.Pathology of the Placenta. London: W. B. Saunders, pp 213–237, 1978.
65.
HubelCA. Dyslipidemia, iron, and oxidative stress in preeclampsia: Assessment of maternal and feto-placental interactions. Sem Reprod Endocrinol16: 75–92, 1998.
66.
StaffAC, RanheimT, KhouryJ, HenriksenT.Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. Am J Obstet Gynecol180: 587–592, 1999.
67.
MagannE, MartinJ, IsaacsJ, PerryK, MartinR, MeydrechE.Immediate postpartum curettage: Accelerated recovery from severe preeclampsia. Obstet Gynecol81: 502–506, 1993.
68.
StaffAC, HalvorsenB, RanheimT, HenriksenT.Free 8-isoprostaglandin F2α is elevated in decidua basalis in women with preeclampsia. Am J Obstet Gynecol (in press).
69.
RobertsLJ, MorrowJD. The isoprostanes: Novel markers of lipid peroxidation and potential mediators of oxidant injury. Adv Prostaglandin Thromboxane Leukot Res23: 219–224, 1995.
70.
WalshSW, WangY.Secretion of lipid peroxides by the human placenta. Am J Obstet Gynecol169: 1462–1466, 1993.
71.
WalshSW, WangY.Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab80: 1888–1893, 1995.
72.
WalshSW, WangY, JesseR.Placental production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. Hypertension Pregnancy15: 101–111, 1996.
73.
WalshSW, WangY, VaughanJE. Placental production of 8-isoprostane is significantly increased in preeclampsia. J Soc Gynecol Invest4: 96A, 1997.
74.
WalshSW, WangY.Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides. Am J Obstet Gynecol169: 1456–1461, 1993.
75.
WarsoMA, LandsWE. Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology. Br Med Bull39: 277–280, 1983.
76.
MoncadaS, VaneJR. The discovery of prostacyclin: A fresh insight into arachidonic acid metabolism. In: KharaschN, FriedJ, Eds. Biochemical Aspects of Prostaglandins. New York: Academic Press, pp 155–177, 1997.
77.
WetzkaB, Charnock-JonesDS, VivilleB, CooperJC, NusingR, ZahradnikHP, SmithSK. Expression of prostacyclin and thromboxane syntheses in placenta and placental bed after preeclamptic pregnancies. Placenta17: 573–581, 1996.
78.
BeckmanJS, KoppenolWH. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly. Am J Physiol271: C1424–C1437, 1996.
79.
BeckmanJS, YeYZ, AndersonPG, ChenJ, AccavittiMA, TarpeyMM, WhiteCR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler375: 81–88, 1994.
80.
KooyNW, RoyallJA, YeYZ, KellyDR, BeckmanJS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med151: 1250–1254, 1995.
81.
MyattL, RosenfieldRB, EisAL, BrockmanDE, GreerI, LyallF.Nitrotyrosine residues in placenta: Evidence of peroxynitrite formation and action. Hypertension28: 488–493, 1996.
82.
LyallF, GibsonJL, GreerIA, BrockmanDE, EisAL, MyattL.Increased nitrotyrosine in the diabetic placenta: Evidence for oxidative stress. Diabetes Care21: 1753–1758, 1998.
83.
KimuraE, KosakaH, ShigaT, YoshimineT, HayakawaT.Elevation of plasma nitric oxide end products during focal cerebral ischemia and reperfusion in the rat. J Cereb Blood Flow Metab14: 487–491, 1994.
84.
KooyNW, RoyallJA. Agonist-induced peroxynitrite production from endothelial cells. Arch Biochem Biophys310: 352–359, 1994.
85.
HalliwellB.What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo?FEBS Lett411: 157–160, 1997.
86.
ManyA, HubelCA, RobertsJM. Hyperuricemia and xanthine oxidase in preeclampsia revisited. Am J Obstet Gynecol174: 288–291, 1996.
87.
KirschnerRE, FantiniGA. Role of iron and oxygen-derived free radicals in ischemia-reperfusion injury. J Am Coll Sur179: 103–117, 1994.
88.
ZhangZ, BlakeDR, StevensCR, KanczlerJM, WinyardPG, SymonsMC, BenboubetraM, HarrisonR.A reappraisal of xanthine dehydrogenase and oxidase in hypoxic reperfusion injury: The role of NADH as an electron donor. Free Radic Res28: 151–164, 1998.
89.
ManyA, Westerhausen-LarsonA, Kanbour-ShakirA, RobertsJM. Xanthine oxidase/dehydrogenase is present in human placenta. Placenta17: 361–365, 1996.
90.
ManyA, FriedmanSA, HubelCA, RobertsJM. Xanthine oxidase activity in preeclamptic women is higher in invasive but not villous trophoblast. J Soc Gynecol Invest3: 36A, 1996.
91.
TakeharaY, YoshiokaT, SasakiJ.Changes in the levels of lipoper-oxide and antioxidant factors in human placenta during gestation. Acta Med Okayama44: 103–111, 1990.
92.
SekibaK, YoshiokaT.Changes of lipid peroxidation and superoxide dismutase activity in the human placenta. Am J Obstet Gynecol135: 368–371, 1979.
93.
PoranenAK, EkbladU, UotilaP, AhotupaM.Lipid peroxidation and antioxidants in normal and preeclamptic pregnancies. Placenta17: 401–405, 1996.
94.
PandeyS, GujratiVR, Chandravati SangerKC, ShankerK.Status of human placental lipid peroxidation, superoxide dismutase, and catalase during pregnancy-induced hypertension (PIH). Asia Pac J Pharmacol10: 41–44, 1995.
95.
WangY, WalshSW. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Invest3: 179–184, 1996.
96.
MyattL, EisAL, BrockmanDE, KossenjansW, GreerIA, LyallF.Differential localization of superoxide dismutase isoforms in placental villous tissue of normotensive, preeclamptic, and intrauterine growth-restricted pregnancies. J Histochem Cytochem45: 1433–1438, 1997.
97.
ChenG, WilsonR, BoydP, McKillipJH, LeitchC, WalkerJJ, BurdonRH. Normal superoxide dismutase (SOD) gene in pregnancy-induced hypertension: Is the decreased SOD activity a secondary phenomenon?Free Radic Res21: 59–66, 1994.
98.
WisdomSJ, WilsonR, McKillipJH, WalkerJJ. Antioxidant systems in normal pregnancy and in pregnancy-induced hypertension. Am J Obstet Gynecol165: 1701–1704, 1991.
99.
LeferDJ, ScaliaR, CampbellB, NossuliT, HaywardR, SalamonM, GraysonJ, LeferAM. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest99: 684–691, 1997.
100.
RoggensackA, ZhangY, DavidgeS.Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension33: 83–89, 1999.
101.
GarzettiGG, TranquilliAL, CuginiAM, MazzantiL, CesterN, RomaniniC.Altered lipid composition, increased lipid peroxidation, and altered fluidity of the membrane as evidence of platelet damage in preeclampsia. Obstet Gynecol81: 337–340, 1993.
102.
MorrisJM, GopaulNK, EndresenMJ, KnightM, LintonEA, DhirS, ÄnggardEE, RedmanCW. Circulating markers of oxidative stress are raised in normal pregnancy and preeclampsia. Br J Obstet Gynaecol105: 1195–1199, 1998.
103.
WangY, WalshSW, GuoJ, ZhangJ.Maternal levels of prostacyclin, thromboxane, vitamin E, and lipid peroxides throughout normal pregnancy. Am J Obstet Gynecol165: 1690–1694, 1991.
104.
DavidgeST, HubelCA, BraydenRD, CapelesEC, McLaughlinMK. Sera antioxidant activity in uncomplicated and preeclamptic pregnancies. Obstet Gynecol79: 897–901, 1992.
105.
LorentzenB, DrevonCA, EndressenMJ, HenriksenT.Fatty acid pattern of esterfied and free fatty acids in sera of women with normal and preeclamptic pregnancy. Br J Obstet Gynaecol102: 530–537, 1995.
106.
FreiB.Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr54: 1113S–1118S, 1991.
107.
BerlinerJA, HeineckeJA. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med20: 707–727, 1996.
108.
JansenH, GhanemH, KuypersJH, BirkenhagerJC. Autoantibodies against malondialdehyde-modified LDL are elevated in subjects with an LDL subclass pattern B. Atherosclerosis115: 255–262, 1995.
109.
ArmstrongVW, WielandE, DiedrichF, RennerA, RathW, KreuzerH, KuhnW, OellerichM.Serum antibodies to oxidised low-density lipoprotein in preeclampsia and coronary heart disease. Lancet343: 1570, 1994.
110.
BranchDW, MitchellMD, MillerE, PalinskiW, WitztumJL. Preeclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet343: 645–646, 1994.
111.
UotilaJ, SolakiviT, JaakkolaO, TuimalaR, LehtimakiT.Antibodies against copper-oxidised and mondialdehyde-modified low-density lipoproteins in preeclamptic pregnancies. Br J Obstet Gynaecol105: 1113–1117, 1998.
112.
KurkiT, AilusK, PalosuoT, YlikorkalaO.Oxidized low-density lipoprotein, cardiolipin, and phosphatidyl serine fail to predict the risk of preeclampsia. Hypertension Pregnancy15: 251–256, 1996.
113.
BasuTK, SchorahCJ. Vitamin C in Health and Disease. Westport, CT: AVI Publishing Co., pp 95–100, 1982.
114.
ClemetsonCA, AndersenL.Ascorbic acid metabolism in preeclampsia. Obstet Gynecol24: 774–782, 1964.
115.
MikhailMS, AnyaegbunamA, GarfinkelD, PalanPR, BasuJ, RomneySL. Preeclampsia and antioxidant nutrients: Decreased plasma levels of reduced ascorbic acid, α-tocopherol, and β-carotene in women with preeclampsia. Am J Obstet Gynecol171: 150–157, 1994.
116.
HubelCA, KaganVE, KisinER, McLaughlinMK, RobertsJM. Increased ascorbate radical formation and ascorbate depletion in plasma from women with preeclampsia: Implications for oxidative stress. Free Radic Biol Med23: 597–609, 1997.
117.
TraberMG. Determinants of plasma vitamin E concentrations. Free Radic Biol Med16: 229–239, 1994.
118.
SchiffE, FriedmanSA, StampferM, KaoL, BarrettPH, SibaiBM. Dietary consumption and plasma concentrations of vitamin E in pregnancies complicated by preeclampsia. Am J Obstet Gynecol175: 1024–1028, 1996.
119.
UotilaJT, TuimalaRJ, AarnioiTM, PyykkoKA, AhotupaMO. Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy. J Obstet Gynecol100: 270–276, 1993.
120.
HubelCA. Plasma vitamin E in preeclampsia. Am J Obstet Gynecol177: 484–485, 1977.
121.
BuettnerTGR, JurkiewiczBA. Chemistry and biochemistry of ascorbic acid. In: CadenasE, PackerL, Eds. Handbook of Antioxidants: Antioxidants in Health and Disease. New York: Marcel Dekker, Inc., pp 91–115, 1996.
122.
TyurinVA, BorisenkoGG, FabisiakJP, HubelCA, McLaughlinMK, RobertsJM, KaganVE. Elevations in chelatable, redox-active copper contribute to increased ascorbate oxidation in plasma from women with preeclampsia, (abstract). J Soc Gynecol Invest6(Suppl 1):169A, 1999.
123.
WalshSW. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Sem Reprod Endocrinol16: 93–104, 1998.
124.
LorentzenB, HenriksenT.Plasma lipids and vascular dysfunction in preeclampsia. Sem Reprod Endocrinol16: 33–39, 1998.
125.
KaajaR.Insulin resistance syndrome in preeclampsia. Sem Reprod Endocrinol16: 41–46, 1998.
HerreraE, LasuncionMA, CoronadoDG, ArandaP, LunaPLO, MaierI.Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy. Am J Obstet Gynecol158: 1575–1583, 1988.
PotterJM, NestelPJ. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol133: 165–170, 1979.
130.
AlvarezJJ, MontelongoA, IglesiasA, LasuncionMA, HerreraE.Longitudinal study on lipoprotein profile, high-density lipoprotein subclass, and postheparin lipases during gestation in women. J Lipid Res37: 299–308, 1996.
131.
ColemanRA. The role of the placenta in lipid metabolism and transport. Sem Perinatol13: 180–191, 1989.
132.
BonetB, BrunzellJD, GownAM, KnoppRH. Metabolism of very low density lipoprotein triglyceride by human placental cells: The role of lilpoprotein lipase. Metabolism41: 596–603, 1992.
133.
HubelCA, McLaughloinMK, EvansRW, HauthBA, SimsCJ, RobertsJM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours postpartum. Am J Obstet Gynecol174: 975–982, 1996.
134.
LorentzenB, EndresenMJ, CalusenT, HenriksenT.Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertension Pregnancy13: 103–109, 1994.
135.
GratacosE, CasalsE, SanllehyC, CararachV, AlonsoPL, FortunyA.Variation in lipid levels during pregnancy in women with different types of hypertension. Acta Obstet Gynecol Scand75: 896–901, 1996.
136.
SattarN, BedomirA, BerryC, ShepherdJ, GreerIak, PackardCJ. Lipoprotein subfraction concentrations in preeclampsia: Pathogenic parallels to atherosclerosis. Obstet Gynecol89: 403–408, 1997.
137.
KaajaR, TikkanenMJ, ViinikkaL, YlikorkalaO.Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol85: 353–356, 1995.
138.
LamarcheB, TchernofA, MauriegeP, CantinB, DagenaisGR, LlupienPJ, DespresJP. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA279: 1955–1961, 1998.
139.
KraussRM. Genetic, metabolic, and dietary influences on the atherogenic lipoprotein phenotype. In: SimopoulosAP, NestelPJ, Eds. Genetic Variation and Dietary Response: World Review of Nutrition and Dietetics. Basel, Switzerland: Karger, Vol 80: pp 2–43, 1997.
140.
LewisGF, SteinerG.Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in noninsulin-dependent diabetes mellitus. Diabetes Metab Rev12: 37–56, 1996.
141.
StampferMJ, KraussRM, MaJ, BlanchePJ, HollLG, SacksFM, HennekensCH. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA276: 882–888, 1996.
142.
AnberR, GriffinBA, McConnellM, PackardCJ, ShepherdJ.Influence of plasma lipid and LDL-subfraction profile on the interaction between low-density lipoprotein with human arterial wall proteoglycans. Atherosclerosis124: 261–271, 1996.
143.
ChaitA, BrazgRL, TribbleDL, KraussRM. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med94: 350–356, 1993.
144.
WeisserB, LocherR, deGraffJ, MoserR, SachinidisA.Low-density lipoprotein subfractions increase thromboxane formation in endothelial cells. Biochem Biophys Res Commun192: 1245–1250, 1993.
145.
WeisserB, LocherR, deGraafJ, VetterW.Low-density lipoprotein subfractions and [Ca2+]i in vascular smooth muscle cells. Circ Res73: 118–124, 1993.
146.
HubelCA, ShakirY, GallaherMJ, McLaughlinMK, RobertsJM. Low-density lipoprotein particle size decreases during normal pregnancy in association with triglyceride increases. J Soc Gynecol Invest5: 244–250, 1998.
147.
ChesleyLC. Hypertension in pregnancy: Definitions, familial factor, and remote prognosis. Kidney Int18: 234–240, 1980.
148.
ArngrimssonR, GeirssonRT, BjornssonS, BjornssonH, WalkerJJ, SnaedalG.Genetic and familial predisposition to eclampsia and preeclampsia in a defined population. Br J Obstet Gynaecol97: 762–769, 1990.
149.
CooperDW, BrenneckeSP, WiltonAN. Genetics of preeclampsia. Hypertension Pregnancy12: 1–23, 1993.
ArngrimssonR, BjornssonH, GeirssonRT. Analysis of different inheritance patterns in preeclampsia/eclampsia syndrome. Hypertension Pregnancy14: 27–38, 1995.
152.
HubelCA, RobertsJM, FerrellRE. Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene. Clinical Genetics (in press).
153.
FisherRM, HumphriesSE, TalmudPJ. Common variation in the lipoprotein lipase gene: Effects on plasma lipids and risk of atherosclerosis. Atherosclerosis135: 145–159, 1997.
154.
HokansonJE, BrunzellJD, JarvikGP, SijsmanEM, AustinMA. Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency. Am J Hum Genet64: 608–618, 1999.
155.
KupfermineMJ, EldorA, SteinmanN, ManyA, Bar-AmA, JaffaA, FaitG, LessingJB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med340: 9–13, 1999.
156.
JonsdottirLS, ArngrimssonR, GeirssonRT, SigvaldasonH, SigfussonN.Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Cand74: 772–776, 1995.
157.
HubelCA, SnaedalS, GeirssonRT, RobertsJM, ArngrimssonR.Women with a history of eclampsia manifest dyslipidemia during later life (abstract). J Soc Gynecol Invest5(Suppl 1):40A, 1998.
158.
BonetB, ChaitA, GownAM, KnoppRH. Metabolism of modified LDL by cultured human placental cells. Atherosclerosis112: 125–136, 1995.
159.
CasascoA, CalligaroA, CasascoM, TateoS, Icaro CornagliaA, ReguzzoniM, FarinaA.Immunohistochemical localization of lipoperoxidation products in normal human placenta. Placenta18: 249–253, 1997.
160.
EsterbauerH.Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr57: 779S–786S, 1993.
SmarasonAK, SargentIL, StarkeyPM, RedmanCW. The effect of placental syncytiotrophoblast microvillous membranes from normal and preeclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol100:943–949, 1993.
MuraiJT, MuzykanskiyE, TaylorRN. Maternal and fetal modulators of lipid metabolism correlate with the development of preeclampsia. Metabolism46: 963–967, 1997.
165.
BenyoDF, MilesTM, ConradKP. Hypoxia stimulates cytokine production by villous expiants from the human placenta. J Clin Endocrinol Metab82: 1582–1588, 1997.
166.
ToborekM, BargerW, MattsonMP, BarveS, McClainCJ, HeningB.Linoleic acid and TNF-a cross-amplify oxidative injury and dysfunction of endothelial cells. J Lipid Res37: 123–135, 1996.
HotamisligilGS, ArnerP, CroJF, AtkinsonRL, SpeigelmanBM. Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance. J Clin Invest95: 2409–2415, 1995.
169.
KernPA, SaghizadehM, OngJM, BoschRJ, DeemR, SimsoloRB. The expression of tumor necrosis factor in human adipose tissue: Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest95: 2111–2119, 1995.
170.
RedmanC, SacksG, SargentI.Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol180: 499–506, 1999.
171.
SacksGP, StudenaK, SargentII, RedmanCW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol179: 80–86, 1998.
172.
ButterworthBH, GreenIA, ListonWA, HaddadNG, JohnstonTA. Immunocytochemical localization of neutrophil elastase in term placenta decidua and myometrium in pregnancy-induced hypertension. Br J Obstet Gynaecol98: 929–933, 1991.
173.
GreerIA, DawesJ, JohnstonTA, CalderAA. Neutrophil activation is confined to the maternal circulation in pregnancy-induced hypertension. Obstet Gynecol78: 28–32, 1991.
174.
JohnstonTA, GreerIA, DawesJ, CalderAA. Neutrophil activation in small for gestational age pregnancies. Br J Obstet Gynaecol98: 978–982, 1989.
175.
GreerIA, LeaskR, HodsonBA, DawesJ, KilpatrickDC, ListonWA. Endothelin, elastase, and endothelial dysfunction in preeclampsia. Lancet337: 558, 1991.
176.
HazenSL, HsuFF, MuellerDM, CrowleyJR, HeineckeJW. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J Clin Invest98: 1283–1289, 1996.
177.
HansenPR, StawskiG.Neutrophil-mediated damage to isolated myocytes after anoxia and reoxygenation. Cardiovasc Res28: 565–569, 1994.
178.
HardySJ, FerranteA, PoulosA, RobinsonBS, JohnsonDW, MurrayAW. Effect of exogenous fatty acids with greater than 22 carbon atoms (very long chain fatty acids) on superoxide production by human neutrophils. J Immunol153: 1754–1761, 1994.
179.
PronaiL, HiramatsuK, SaigusaY, NakazawaH.Low superoxide scavenging activity associated with enhanced superoxide generation by monocytes from male hypertriglyceridemia with and without diabetes. Atherosclerosis90: 39–47, 1991.
180.
GorogP.Activation of human blood monocytes by oxidized polyunsaturated fatty acids: A possible mechanism for the generation of lipid peroxides in the circulation. Int J Exp Pathol72: 227–237, 1991.
181.
MaebaR, MaruyamaA, TarutaniO, UeaN, ShimasakiH.Oxidized low-density lipoprotein induces the production of superoxide by neutrophils. FEBS Lett377: 309–312, 1995.
182.
UhlingerDJ, BurnhamDN, MullinsRE, KalmarJR, CullerCW, ArnoldRR, LambethJD, MerrillAH. Functional differences in human neutrophils isolated pre- and postprandially. FEBS Lett286: 28–32, 1991.
183.
HoogerbruggeN, VerkerkA, JacobsML, PostemaPTE, JongkindJF. Hypertriglyceridemia enhances monocyte binding to endothelial cells in NIDDM. Diabetes Care19: 1122–1125, 1996.
SimonBC, CunninghamLD, CohenRA. Oxidized low-density lipoproteins cause contraction and inihibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest86: 75–79, 1990.
194.
RemuzziG, MarchesiD, ZojaC, MuratoreD, MeccaG, MisianiR, RossiE, BarbatoM, CapettaP, DonatiMB, GaetanoGD. Reduced umbilical and placental vascular prostacyclin in severe preeclampsia. Prostaglandins20: 105–110, 1980.
195.
FalangaA, DoniMG, DelainiF.Unbalanced control of TxA2 and PGI2 synthesis in vitamin E-deficient rats. Am J Physiol245: H867–H870, 1983.
196.
PetersJH, GinsbergMH, BohlBP, SklarLA, CochraneCG. Intravascular release of intact cellular fibronectin during oxidant-induced injury of the in vitro perfused rabbit lung. J Clin Invest78: 1596–1603, 1986.
197.
BakerPN, DavidgeST, RobertsJM. Plasma from patients with preeclampsia increases endothelial cell nitric oxide production. Hypertension26: 244–248, 1995.
198.
DavidgeST, BakerPN, RobertsJM. NOS expression is increased in endothelial cells exposed to plasma from women with preeclampsia. Am J Physiol269: H1106–H1112, 1995.
HirataK, MikiN, KurodaY, SakodaT, KawashimaS, YokoyamaM.Low concentration of oxidized low-density lipoprotein and lysophos-phatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells. Circ Res76: 958–962, 1995.
201.
BakerPN, DavidgeST, BarankiewiczJ, RobertsJM. Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin. Hypertension27: 56–61, 1996.
202.
MyersDE, HuangWN, LarkinsRG. Lipoprotein-induced prostacyclin production in endothelial cells and effects of lipoprotein modification. Am J Physiol271: C1504–C1511, 1996.
203.
WangJ, ZhenE, GuoZ, LuY.Effect of hyperlipidcmic serum on lipid peroxidation, synthesis of prostacyclin and thromboxane by cultured endothelial cells: Protective effect of antioxidants. Free Radic Biol Med7: 243–249, 1989.
204.
SpickettC, ReglinskiJ, SmithW, WilsonR, WalkerJ, McKillopJ.Erythrocyte glutathione balance and membrane stability during preeclampsia. Free Radic Biol Med24: 1049–1055, 1998.
205.
ChiuD, LubinB, SohetSB. Peroxidative reactions in red cell biology. In: PryorWA, Ed. Free Radicals in Biology. New York: Academic Press, pp 115–120, 1982.
206.
NardulliG, ProverbioF, LimongiFG, MarinR, ProverbioT.Preeclampsia and calcium adenosine triphosphate activity of red blood cell ghosts. Am J Obstet Gynecol171: 1361–1365, 1994.
